Xenetic Biosciences Other Current Liabilities

Xenetic Biosciences (XBIO) currently reports a other current liabilities of $570K as of June 2026. That compares with $560K in the prior-year period — up 2.8% year over year. Use the charts on this page to explore Xenetic Biosciences's other current liabilities history and peer comparisons.

Xenetic Biosciences's other current liabilities increased from $560K to $570K — a 2.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Xenetic Biosciences reported $570K in other current liabilities as of June 2026. That compares with $560K in the prior-year period — up 2.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $570K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Xenetic Biosciences, and consider following XBIO for alerts when major investors trade the stock.

Xenetic Biosciences is classified in the Healthcare sector. On other current liabilities, it currently shows $570K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XBIO with unrelated industries.